NOT FOR DISTRIBUTION
Header cover image

Bastide Le Confort Médical

Market Cap

€332.8m

Last Updated

2021/05/10 04:30 UTC

Data Sources

Company Financials +

Executive Summary

Bastide Le Confort Médical SA engages in the sale and rental of medical equipment in France. More Details


Snowflake Analysis

Proven track record and fair value.

Share Price & News

How has Bastide Le Confort Médical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine BLCP's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine BLCP's volatility change over the past year.


Market Performance


7 Day Return

0%

BLCP

0.7%

GB Healthcare

2.1%

GB Market


1 Year Return

64.6%

BLCP

52.5%

GB Healthcare

26.3%

GB Market

Return vs Industry: BLCP exceeded the UK Healthcare industry which returned 52.5% over the past year.

Return vs Market: BLCP exceeded the UK Market which returned 26.3% over the past year.


Shareholder returns

BLCPIndustryMarket
7 Day0%0.7%2.1%
30 Day0%7.4%3.5%
90 Dayn/a12.0%8.8%
1 Year65.5%64.6%54.6%52.5%31.9%26.3%
3 Year4.7%3.3%-14.4%-18.7%12.9%-0.1%
5 Year184.1%175.8%-15.6%-21.6%51.5%22.8%

Long-Term Price Volatility Vs. Market

How volatile is Bastide Le Confort Médical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Bastide Le Confort Médical undervalued compared to its fair value and its price relative to the market?

46.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: BLCP (€53.5) is trading below our estimate of fair value (€99.91)

Significantly Below Fair Value: BLCP is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: BLCP is good value based on its PE Ratio (29.9x) compared to the GB Healthcare industry average (32.6x).

PE vs Market: BLCP is poor value based on its PE Ratio (29.9x) compared to the UK market (26.4x).


Price to Earnings Growth Ratio

PEG Ratio: BLCP is poor value based on its PEG Ratio (1.7x)


Price to Book Ratio

PB vs Industry: BLCP is overvalued based on its PB Ratio (4.5x) compared to the GB Healthcare industry average (2.1x).


Future Growth

How is Bastide Le Confort Médical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

18.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BLCP's forecast earnings growth (18% per year) is above the savings rate (0.9%).

Earnings vs Market: BLCP's earnings (18% per year) are forecast to grow faster than the UK market (17.5% per year).

High Growth Earnings: BLCP's earnings are forecast to grow, but not significantly.

Revenue vs Market: BLCP's revenue (3.8% per year) is forecast to grow slower than the UK market (5.3% per year).

High Growth Revenue: BLCP's revenue (3.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BLCP's Return on Equity is forecast to be low in 3 years time (17.4%).


Past Performance

How has Bastide Le Confort Médical performed over the past 5 years?

10.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BLCP has a large one-off loss of €5.9M impacting its December 31 2020 financial results.

Growing Profit Margin: BLCP's current net profit margins (2.6%) are higher than last year (2%).


Past Earnings Growth Analysis

Earnings Trend: BLCP's earnings have grown by 10.5% per year over the past 5 years.

Accelerating Growth: BLCP's earnings growth over the past year (61%) exceeds its 5-year average (10.5% per year).

Earnings vs Industry: BLCP earnings growth over the past year (61%) exceeded the Healthcare industry 15.3%.


Return on Equity

High ROE: BLCP's Return on Equity (15.8%) is considered low.


Financial Health

How is Bastide Le Confort Médical's financial position?


Financial Position Analysis

Short Term Liabilities: BLCP's short term assets (€182.8M) exceed its short term liabilities (€168.7M).

Long Term Liabilities: BLCP's short term assets (€182.8M) do not cover its long term liabilities (€314.4M).


Debt to Equity History and Analysis

Debt Level: BLCP's debt to equity ratio (343.4%) is considered high.

Reducing Debt: BLCP's debt to equity ratio has increased from 97.1% to 343.4% over the past 5 years.

Debt Coverage: BLCP's debt is well covered by operating cash flow (20.5%).

Interest Coverage: BLCP's interest payments on its debt are well covered by EBIT (4.3x coverage).


Balance Sheet


Dividend

What is Bastide Le Confort Médical current dividend yield, its reliability and sustainability?

0.59%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: BLCP's dividend (0.59%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.35%).

High Dividend: BLCP's dividend (0.59%) is low compared to the top 25% of dividend payers in the UK market (4.03%).


Stability and Growth of Payments

Stable Dividend: BLCP is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.

Growing Dividend: BLCP is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: BLCP is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BLCP's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average board tenure


CEO

Guy Bastide (81 yo)

no data

Tenure

€7,422

Compensation

Mr. Guy Bastide serves as the Chief Executive Officer of Alliance Terroirs (alternate name Bessiere S.A). Mr. Bastide has been as Chief Executive Officer of Bastide Le Confort Médical SA (formerly known as...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Guy's total compensation is reasonable compared to companies of similar size in the UK market.

Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: BLCP's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Bastide Le Confort Médical SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bastide Le Confort Médical SA
  • Ticker: BLCP
  • Exchange: BATS-CHIXE
  • Founded: 1977
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: €332.792m
  • Shares outstanding: 7.31m
  • Website: https://www.bastideleconfortmedical.com

Number of Employees


Location

  • Bastide Le Confort Médical SA
  • Activity Center Euro 2000
  • 12, avenue de la dame
  • Caissargues
  • Languedoc-Roussillon
  • 30132
  • France

Listings


Biography

Bastide Le Confort Médical SA engages in the sale and rental of medical equipment in France. The company offers comfort and health products, such as lift chairs, bathroom and well-being products, pillows a...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/10 04:30
End of Day Share Price2021/02/18 00:00
Earnings2020/12/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.